Price $3.77 |
Market Cap
56.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.71
|
P/S
0.91
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-5K
|
FCF
-0.7
|
|
Op. Margin
-3.50%
|
Net Margin
-4.00%
|
ROE
-8.70%
|
ROI
-59.00%
|
|
ROA
-4.90%
|
EPS Growth
98.10%
|
Current Ratio
2.6
|
Debt/Equity
6.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generex Biotechnology Corporat (GNBT) | $0.08 | - | - | 18.7M | Strong Buy |
| Novo Integrated Sciences Inc (NVOS) | $1.40 | - | - | 45.3M | Strong Buy |
| Capital Senior Living Corporat (CSU) | $33.54 | - | - | 63M | Strong Buy |
| Organon & Co (OGN) | $28.83 | - | 3.00% | 9.26B | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $2.35 | - | - | 15.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
